ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
8.27
-0.07 (-0.84%)
At close: Oct 8, 2025, 4:00 PM EDT
8.27
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT

Company Description

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.

The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025.

ImageneBio, Inc. is headquartered in San Diego, California.

ImageneBio, Inc.
ImageneBio logo
CountryUnited States
Founded2019
IndustryBiotechnology
SectorHealthcare

Contact Details

Address:
12526 High Bluff Drive, Suite 345
San Diego, California 92130
United States
Phone858 345 6265
Websiteinmagenebio.com

Stock Details

Ticker SymbolIMA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001835579
Employer ID81-1697316
SIC Code2836

Latest SEC Filings

DateTypeTitle
Sep 15, 2025EFFECTNotice of Effectiveness
Sep 8, 2025S-1General form for registration of securities under the Securities Act of 1933
Aug 12, 20258-K/A[Amend] Current report
Aug 5, 20258-KCurrent Report
Aug 4, 2025SCHEDULE 13GFiling
Aug 4, 2025SCHEDULE 13G/AFiling
Aug 1, 20258-KCurrent Report
Jul 30, 2025SCHEDULE 13D/AFiling
Jul 29, 2025SCHEDULE 13D/AFiling
Jul 29, 20258-KCurrent Report